TotalMarketCap

BioNTech SE

BNTXNasdaq GermanyHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$21.605 B

$86.01 -5.18%

Close of 6 Nov 2026

As of 6 Nov 2026, BioNTech SE (BNTX) has a market capitalization of $21.6B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

251,204,366

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #5Revolution MedicinesRVMD$38.5B
  2. #6BiogenBIIB$36.1B
  3. #7BioNTech SEBNTX$21.6B
  4. #8ExelixisEXEL$16.8B
  5. #9Neurocrine BiosciencesNBIX$16.2B

What if BioNTech SE were worth as much as…

Open the what-if tool →

Gold $28.2T

$112,405.98

Per share 1,307× higher

Bitcoin $1.53T

$6,082.09

Per share 70.7× higher

Apple $5.02T

$19,966.94

Per share 232× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for BioNTech SE are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.